Drug Type Small molecule drug |
Synonyms- |
Target |
Action agonists |
Mechanism 20S proteasome agonists(20S proteasome agonists) |
Therapeutic Areas |
Active Indication- |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedDiscovery |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Cardiovascular Diseases | Discovery | - | 27 Jun 2025 | |
| Endocrinology and Metabolic Disease | Discovery | - | 27 Jun 2025 | |
| Metabolic dysfunction-associated steatotic liver disease | Discovery | - | 27 Jun 2025 | |
| Nervous System Diseases | Discovery | - | 27 Jun 2025 | |
| Sclerosteosis | Discovery | - | 27 Jun 2025 |





